Women's Experiences With Family Planning Under COVID-19: A Cross-Sectional, Interactive Voice Response Survey in Malawi, Nepal, Niger, and Uganda.


Journal

Global health, science and practice
ISSN: 2169-575X
Titre abrégé: Glob Health Sci Pract
Pays: United States
ID NLM: 101624414

Informations de publication

Date de publication:
30 08 2022
Historique:
received: 16 02 2022
accepted: 12 07 2022
entrez: 30 8 2022
pubmed: 31 8 2022
medline: 3 9 2022
Statut: epublish

Résumé

We conducted an assessment in Malawi, Nepal, Niger, and Uganda to document access-related reasons for not using contraceptive methods during the COVID-19 pandemic that led to unintended pregnancies, describe use of modern contraception among women in potential need of contraception compared to before the pandemic, examine method choice, and describe barriers to contraceptive access and use. Between December 2020 and May 2021, we conducted an opt-in phone survey with 21,692 women, followed by an outbound survey with 5,124 women who used modern nonpermanent contraceptive methods or who did not want to get pregnant within 2 years but were not using a modern contraceptive method. The surveys examined current behaviors and documented behaviors before the pandemic retrospectively. We used multivariable logistic regression models to examine factors associated with contraceptive use dynamics during COVID-19. Pregnant women surveyed reported that the pandemic had affected their ability to delay or avoid getting pregnant, ranging from 27% in Nepal to 44% in Uganda. The percentage of respondents to the outbound survey using modern contraception decreased during the pandemic in all countries except Niger. Fear of COVID-19 infection was associated with discontinuing modern contraception in Malawi and with not adopting a modern method among nonusers in Niger. Over 79% of surveyed users were using their preferred method. Among nonusers who tried obtaining a method, reasons for nonuse included unavailability of the preferred method or of providers and lack of money; nonusers who wanted a method but did not try to obtain one cited fear of COVID-19 infection. We found evidence of surveyed women attributing unintended pregnancies to the pandemic and examples of constraints to contraceptive access and use on the supply and demand side. The effects of the pandemic must be interpreted within the local contraceptive, health system, and epidemiological context.

Identifiants

pubmed: 36041839
pii: GHSP-D-22-00063
doi: 10.9745/GHSP-D-22-00063
pmc: PMC9426982
pii:
doi:

Substances chimiques

Contraceptive Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Brunie et al.

Références

Glob Health Sci Pract. 2020 Jun 30;8(2):220-238
pubmed: 32606092
Sex Reprod Health Matters. 2021 Dec;29(1):1881210
pubmed: 33599196
Front Public Health. 2016 Oct 10;4:222
pubmed: 27777926
Glob Health Sci Pract. 2020 Jun 30;8(2):166-168
pubmed: 32312738
PLoS One. 2018 Jan 19;13(1):e0190902
pubmed: 29351349
Cell Host Microbe. 2021 Jul 14;29(7):1036-1039
pubmed: 34265241
Glob Health Sci Pract. 2016 Sep 29;4(3):366-72
pubmed: 27577239
Glob Health Sci Pract. 2020 Jun 30;8(2):169-175
pubmed: 32561528
Int Perspect Sex Reprod Health. 2020 Apr 16;46:73-76
pubmed: 32343244
Afr J Reprod Health. 2019 Dec;23(4):19-26
pubmed: 32227736
Lancet Glob Health. 2021 Jun;9(6):e793-e801
pubmed: 34019835
BMJ Sex Reprod Health. 2021 Oct;47(4):252-260
pubmed: 33579717
PLoS One. 2019 Apr 10;14(4):e0214450
pubmed: 30969975

Auteurs

Aurélie Brunie (A)

FHI 360, Washington DC, USA. ABrunie@fhi360.org.

Gwyneth Austin (G)

FHI 360, Durham, NC, USA.

Jamie Arkin (J)

Viamo, Nairobi, Kenya; Now with AInfluence Inc, Nairobi, Kenya.

Samantha Archie (S)

FHI 360, Durham, NC, USA.

Dinah Amongin (D)

Makerere University School of Public Health, Kampala, Uganda.

Rawlance Ndejjo (R)

Makerere University School of Public Health, Kampala, Uganda.

Saujanya Acharya (S)

Viamo, Kathmandu, Nepal.

Basant Thapa (B)

FHI 360, Kathmandu, Nepal.

Sarah Brittingham (S)

FHI 360, Durham, NC, USA.

Grace McLain (G)

FHI 360, Durham, NC, USA.

Philip Mkandawire (P)

PSI, Lilongwe, Malawi.

Maimouna Hallidou Doudou (MH)

Evidence for Sustainable Human Development Systems in Africa, and Université Africaine Privée pour le Développement, Niamey, Niger.

Ndola Prata (N)

Evidence for Sustainable Human Development Systems in Africa, University of California, Berkeley, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH